Braveheart Bio, Inc. carries a market capitalization of 1.89B, placing it among publicly traded companies globally.
| Market Cap | 1.89B |
| Enterprise Value | N/A |
Braveheart Bio, Inc.'s stock has gained approximately 48.5% over the past 52 weeks. The 50-day moving average sits at 27.39, while the 200-day moving average is 27.39.
| Beta (5Y) | N/A |
| 52-Week Price Change | 48.5% |
| 50-Day Moving Average | 27.39 |
| 200-Day Moving Average | 27.39 |
| Average Volume (20 Days) | N/A |